These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 20846089)
61. The natural product CCR5 antagonist anibamine and its analogs as anti-prostate cancer agents. Haney KM; Zhang F; Arnatt CK; Yuan Y; Li G; Ware JL; Gewirtz DA; Zhang Y Bioorg Med Chem Lett; 2011 Sep; 21(18):5159-63. PubMed ID: 21820898 [TBL] [Abstract][Full Text] [Related]
62. Novel derivatives of 1,3,4-oxadiazoles are potent mitostatic agents featuring strong microtubule depolymerizing activity in the sea urchin embryo and cell culture assays. Kiselyov AS; Semenova MN; Chernyshova NB; Leitao A; Samet AV; Kislyi KA; Raihstat MM; Oprea T; Lemcke H; Lantow M; Weiss DG; Ikizalp NN; Kuznetsov SA; Semenov VV Eur J Med Chem; 2010 May; 45(5):1683-97. PubMed ID: 20110137 [TBL] [Abstract][Full Text] [Related]
63. Design, synthesis and biological evaluation of trans 2-(thiophen-2-yl)vinyl heteroaromatic iodides. Fortuna CG; Barresi V; Musumarra G Bioorg Med Chem; 2010 Jun; 18(12):4516-23. PubMed ID: 20488719 [TBL] [Abstract][Full Text] [Related]
64. Synthesis and biological activity of stable and potent antitumor agents, aniline nitrogen mustards linked to 9-anilinoacridines via a urea linkage. Kapuriya N; Kapuriya K; Zhang X; Chou TC; Kakadiya R; Wu YT; Tsai TH; Chen YT; Lee TC; Shah A; Naliapara Y; Su TL Bioorg Med Chem; 2008 May; 16(10):5413-23. PubMed ID: 18450456 [TBL] [Abstract][Full Text] [Related]
65. New class of potent antitumor acylhydrazone derivatives containing furan. Cui Z; Li Y; Ling Y; Huang J; Cui J; Wang R; Yang X Eur J Med Chem; 2010 Dec; 45(12):5576-84. PubMed ID: 20884091 [TBL] [Abstract][Full Text] [Related]
66. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors. Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039 [TBL] [Abstract][Full Text] [Related]
68. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents. El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526 [TBL] [Abstract][Full Text] [Related]
69. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid. Csuk R; Schwarz S; Kluge R; Ströhl D Eur J Med Chem; 2010 Dec; 45(12):5718-23. PubMed ID: 20884085 [TBL] [Abstract][Full Text] [Related]
70. Design, synthesis, and antitumor activity of new bis-aminomethylnaphthalenes. Bollini M; Casal JJ; Bruno AM Bioorg Med Chem; 2008 Sep; 16(17):8003-10. PubMed ID: 18715786 [TBL] [Abstract][Full Text] [Related]
71. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102 [TBL] [Abstract][Full Text] [Related]
72. Synthesis and biological evaluation of indolyl chalcones as antitumor agents. Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724 [TBL] [Abstract][Full Text] [Related]
73. Discovery of novel diaryl urea derivatives bearing a triazole moiety as potential antitumor agents. Qin M; Yan S; Wang L; Zhang H; Zhao Y; Wu S; Wu D; Gong P Eur J Med Chem; 2016 Jun; 115():1-13. PubMed ID: 26991938 [TBL] [Abstract][Full Text] [Related]
74. Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay. Griffiths M; Sundaram H Methods Mol Biol; 2011; 731():451-65. PubMed ID: 21516428 [TBL] [Abstract][Full Text] [Related]
75. Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonists. Manera C; Saccomanni G; Adinolfi B; Benetti V; Ligresti A; Cascio MG; Tuccinardi T; Lucchesi V; Martinelli A; Nieri P; Masini E; Di Marzo V; Ferrarini PL J Med Chem; 2009 Jun; 52(12):3644-51. PubMed ID: 19435366 [TBL] [Abstract][Full Text] [Related]
76. CoMFA and docking studies of 2-phenylindole derivatives with anticancer activity. Liao SY; Qian L; Miao TF; Lu HL; Zheng KC Eur J Med Chem; 2009 Jul; 44(7):2822-7. PubMed ID: 19167135 [TBL] [Abstract][Full Text] [Related]
77. Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors. Itoh Y; Suzuki T; Kouketsu A; Suzuki N; Maeda S; Yoshida M; Nakagawa H; Miyata N J Med Chem; 2007 Nov; 50(22):5425-38. PubMed ID: 17929798 [TBL] [Abstract][Full Text] [Related]
78. Benzoylurea derivatives as a novel class of antimitotic agents: synthesis, anticancer activity, and structure-activity relationships. Song DQ; Wang Y; Wu LZ; Yang P; Wang YM; Gao LM; Li Y; Qu JR; Wang YH; Li YH; Du NN; Han YX; Zhang ZP; Jiang JD J Med Chem; 2008 Jun; 51(11):3094-103. PubMed ID: 18457382 [TBL] [Abstract][Full Text] [Related]
79. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives. Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955 [TBL] [Abstract][Full Text] [Related]
80. Bivalent bendamustine and melphalan derivatives as anticancer agents. Scutaru AM; Wenzel M; Gust R Eur J Med Chem; 2011 May; 46(5):1604-15. PubMed ID: 21371790 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]